Zentrum für Kinder- und Jugendmedizin, Angelika-Lautenschläger-Klinik, Onkologie
Welcome,         Profile    Billing    Logout  
 11 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Witt, Olaf
HIT-HGG-2013, NCT03243461 / 2013-004187-56: International Cooperative Phase III Trial of the HIT-HGG Study Group

Recruiting
3
167
Europe
Temozolomide + Valproic Acid
University of Göttingen, Deutsche Kinderkrebsstiftung, Hannover Medical School
Glioblastoma WHO Grade IV, Diffuse Midline Glioma Histone 3 K27M WHO Grade IV, Anaplastic Astrocytoma WHO Grade III, Diffuse Intrinsic Pontine Glioma, Gliomatosis Cerebri
12/23
12/23
NCT06161974: Study of Olutasidenib and Temozolomide in HGG

Not yet recruiting
2
60
Europe, Canada, US, RoW
Olutasidenib + TMZ
Rigel Pharmaceuticals, Nationwide Children's Hospital
High Grade Glioma, Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, Diffuse Intrinsic Pontine Glioma, WHO Grade III Glioma, WHO Grade IV Glioma, Metastatic Brain Tumor, Diffuse Midline Glioma, H3 K27M-Mutant, Thalamus Tumor, Spinal Tumor, IDH1 Mutation, IDH1 R132, IDH1 R132C, IDH1 R132H, IDH1 R132S, IDH1 R132G, IDH1 R132L, Oligodendroglioma
06/29
06/35
NCT05233397: ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Recruiting
2
38
Canada, US, RoW
Tocilizumab, ACTEMRA®
Nationwide Children's Hospital, Children's Hospital Colorado
Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
12/25
12/27
NCT05286788: MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Recruiting
2
38
Canada, US, RoW
Binimetinib Oral Tablet [Mektovi], MEKTOVI
Nationwide Children's Hospital, Children's Hospital Colorado
Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
04/25
04/27
NCT05843253: Study of Ribociclib and Everolimus in HGG and DIPG

Recruiting
2
100
Europe, Canada, US, RoW
Ribociclib, Kisqali, Everolimus, Afinitor
Nationwide Children's Hospital, Novartis
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma, Glioblastoma Multiforme, Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Brain Tumor, WHO Grade III Glioma, WHO Grade IV Glioma
08/28
08/34
NCT05839379: Targeted Pediatric High-Grade Glioma Therapy

Recruiting
2
450
Europe, Canada, US, RoW
Nationwide Children's Hospital
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma, Glioblastoma Multiforme, Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Brain Tumor, WHO Grade III Glioma, WHO Grade IV Glioma
08/29
08/34
INFORM2 NivEnt, NCT03838042 / 2018-000127-14 / ACTRN12619001768189: INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies

Recruiting
1/2
91
Europe, RoW
Nivolumab and Entinostat, Opdivo
University Hospital Heidelberg, German Cancer Research Center
Solid tumour, Central nervous system (CNS) tumour
06/26
06/27
ESMART, NCT02813135 / 2016-000133-40: European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

Recruiting
1/2
455
Europe
Ribociclib, Kisqali, LEE011, Topotecan, Hycamtin, Temozolomide, Temodar, Everolimus, Afinitor, votubia, Adavosertib, AZD1775, Carboplatin, Paraplatin, Olaparib, Lynparza, Irinotecan, Camptosar, CPT-11, Vistusertib, AZD2014, Nivolumab, Opdivo, Cyclophosphamide, Cytoxan, Selumetinib, Koselugo, Enasidenib, Idhifa, Lirilumab, BMS-986015, Fadraciclib, CYC065, Cytarabine, Arabinosylcytosine, Cytosar-U, Dexamethasone, Decadron, Dexasone, Diodex, Hexadrol, Maxidex, Ceralasertib, AZD6738, Futibatinib, Tas-120, Capmatinib, Tabrecta, INC280, Avelumab, BAVENCIO, Peposertib
Gustave Roussy, Cancer Campus, Grand Paris, National Cancer Institute, France
Pediatric Cancer
02/31
02/31
NCT04610736 / 2020-003733-38: TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide

Active, not recruiting
1
49
Europe
Temozolomide Oral Suspension, KIMOZO, Ped-TMZ
Orphelia Pharma, ClinSearch
Pediatric Cancer
01/23
07/23
NCT06333899: Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Not yet recruiting
1
15
Europe, Canada, US, RoW
Lorlatinib, LOBRENA, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2, Lorlatinib post Radiation
Nationwide Children's Hospital, Pfizer
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Infant Type Hemispheric Glioma, Glioblastoma, Glioblastoma Multiforme, WHO Grade III Glioma, WHO Grade IV Glioma, Diffuse Midline Glioma, H3K27-altered
09/27
09/34
CONNECT1903, NCT04655404: A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Recruiting
1
15
Europe, Canada, US, RoW
Larotrectinib, Larotrectinib surgical
Nationwide Children's Hospital
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
12/25
12/25
Haberkorn, Uwe
No trials found
Haufe, Sabine
No trials found

Download Options